Are These Biotech Penny Stocks on Your Watchlist?
As April comes to an end, investors are still searching for the best penny stocks to buy. Whether due to the pandemic or not, 2021 has been the year for biotech penny stocks. While Covid had a negative impact on most industries last year, many have since recovered, with some even pushing new all-time highs. And yes, the coronavirus has emphasized biotech penny stocks producing either a vaccine or treatment for SARS-CoV-2. However, we have seen companies working outside of pandemic-related treatments, also rise in value.
This increase in attention from Covid-19 is the best explanation for the solid biotech industry performance we are seeing. On April 23rd, the Health Care Select Sector SPDR Fund (XLV) reached a new record high of $123.81. This is an incredibly important indicator of how the sector as a whole is doing. Because it just hit a new high, it could be indicative of overall bullish sentiment.
April 20, 2021 | Economic Boom Could Put a Spring in Your Portfolio!
Sean Brodrick Sean is the natural resource analyst for Weiss Group. You can read his thoughts on gold, oil, cannabis, uranium and other natural resources at Wealth-Wave.com
We’re presently in the dead of winter economically speaking where government oversight holds sway over economic, political and social life.
What comes after winter? That would be spring …
… with new innovation from the private sector and economic boom times into the SIXTH Kondratieff Wave!
Nikolai D. Kondratieff’s views were anathema to Soviet communists, as they suggested that capitalist nations were not on an inevitable path to destruction but simply experienced ups and downs.
Apr 21, 2021 at 6:42AM
Investing in a dividend stock that doesn t increase in value means that over the years, inflation will chip away at your recurring payments. Buying shares of a stock that typically raises its payouts can be a great way to not just hedge against that risk, but also lead to more cash flow for you and your portfolio over the long term. For a dividend to double within a span of five years means that a company has raised its payouts by roughly 15% every year.
That s a high percentage, but both
Broadcom (NASDAQ:AVGO) have hiked their dividend payments at even greater rates. Below, I ll look at just how much their payouts have risen, whether there is room for more rate hikes, and if you should add these income stocks to your portfolio today.
Adobe (NASDAQ:ADBE) may not be terribly cheap picks today, but they could still make for solid long-term investments that you can buy and hold for years.
Image source: Getty Images
1. DexCom
Medical device company DexCom makes life a little bit easier for people living with diabetes. Its G6 continuous glucose monitoring (CGM) system sends users real-time glucose readings. It doesn t require finger sticks, either. With convenience and ease of use in mind, the CGM has quickly become the company s flagship product. Earlier this year, DexCom partnered with
Teladoc Health (NYSE:TDOC) to help provide users of its platform with reports and information to help manage their blood glucose levels, at no additional cost.